Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

Jeremy S. Abramson, M. Lia Palomba, Leo I. Gordon, +19

The Lancet

Hematological MalignancyLymphoid NeoplasiaOncologyTranscend Nhl 001Lisocabtagene Maraleucel +3

Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia

Daniel A. Pollyea, Brett M. Stevens, Courtney L. Jones, +14

Nature Medicine

Hematological MalignancyMedicineAcute Myeloid LeukemiaStem CellsPharmacology +7

Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

Jerald P. Radich, Michael W. Deininger, Camille N. Abboud, +27

Journal of the National Comprehensive Cancer Network

Hematological MalignancyChronic Myeloid LeukemiaMedicinePhiladelphia ChromosomeCancer Management +12

Updated safety and long term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL.

Jeremy S. Abramson, Leo I. Gordon, Maria Lia Palomba, +14

Journal of Clinical Oncology

Drug SafetyPivotal TrialEngineeringClinical TherapeuticR/r Aggressive Nhl +12

Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001

Jeremy S. Abramson, M. Lia Palomba, Leo I. Gordon, +14

Blood

Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia

Amanda Winters, Jonathan A. Gutman, Enkhtsetseg Purev, +18

Blood Advances

Pivotal Safety and Efficacy Results from Transcend NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel (liso-cel) in Relapsed/Refractory (R/R) Large B Cell Lymphomas

Jeremy S. Abramson, Maria Lia Palomba, Leo I. Gordon, +16

Blood

Subversion of Systemic Glucose Metabolism as a Mechanism to Support the Growth of Leukemia Cells

Haobin Ye, Biniam Adane, Nabilah Khan, +14

Cancer Cell

Developmental BiologyMetabolic ReprogrammingLeukemia CellsMetabolic RegulationSystemic Glucose Metabolism +7

High-Grade Glioma Formation Results from Postnatal Pten Loss or Mutant Epidermal Growth Factor Receptor Expression in a Transgenic Mouse Glioma Model

Qingxia Wei, Laura Clarke, Danielle K. Scheidenhelm, +16

Cancer Research

NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017

Arnel Pallera, Jessica K. Altman, Ellin Berman, +27

Journal of the National Comprehensive Cancer Network

FertilityMixed-phenotype Acute LeukemiaReproductive HealthNccn Guidelines InsightsGynecology +14